Dr. Paul Spagnuolo received his Ph.D. from the University of Waterloo in 2008 and was a post-doctoral fellow in Dr. Aaron Schimmer’s lab at the Princess Margaret Cancer Centre from 2008-2012. His research focuses on the development of novel therapeutics for the treatment of acute myeloid leukemia with specific emphasis on nutraceuticals (i.e., food-derived bioactive compounds). He has participated in projects that have resulted in the discovery of 8 novel anti-cancer agents, 4 patents and 1 clinical trial. He was recently awarded the Mead Johnson Award from the American Society for Nutrition, which recognizes a young investigator for a single outstanding piece of nutrition research. His research is or has been supported by the Canadian Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, Stem Cell Network, and Leukemia and Lymphoma Society of Canada. He also sits on the Board of Directors for the Natural Health Products Research Society.